Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)
Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)
批准号:
474600
负责人:
Roberts Jason D
金额:
$49.71万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-07-01 至 2025-07-01
中文摘要
心律失常性右室心肌病(ARVC)是一种遗传性心脏病,其特征是心脏组织被疤痕和脂肪异常替代。受影响的患者容易出现心力衰竭、危险的心跳加速和猝死
英文摘要
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic form of heart disease characterized by abnormal replacement of heart tissue with scar and fat. Affected patients are vulnerable to heart failure, dangerous fast heart beats, and sudden de
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Calcium Release Deficiency Syndrome: Establishing a Clinical Diagnostic Test and an International Registry
-
批准号:478350
-
项目类别:Operating Grants
-
资助金额:$78.02万
-
财政年份:2023
-
负责人:Roberts Jason D
-
依托单位:
Prize 202203PJT - RYR2-targeted Gene Therapies for Treating Catecholaminergic Polymorphic Ventricular Tachycardia
-
批准号:467980
-
项目类别:Operating Grants
-
资助金额:$2.19万
-
财政年份:2022
-
负责人:Roberts Jason D
-
依托单位:
RYR2-targeted Gene Therapies for Treating Catecholaminergic Polymorphic Ventricular Tachycardia
-
批准号:461749
-
项目类别:Operating Grants
-
资助金额:$77.74万
-
财政年份:2022
-
负责人:Roberts Jason D
-
依托单位:
Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)
-
批准号:466287
-
项目类别:Operating Grants
-
资助金额:$198.82万
-
财政年份:2022
-
负责人:Roberts Jason D
-
依托单位:
The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest: The EPS ARREST Study
-
批准号:380791
-
项目类别:Operating Grants
-
资助金额:$13.11万
-
财政年份:2018
-
负责人:Roberts Jason D
-
依托单位:
海外基金